You Get What You Pay For: Breast MRI Screening of Women With Dense Breasts Is Cost-effective
Menée à l'aide d'un modèle de microsimulation, cette étude compare le rapport coût-efficacité de différentes stratégies de dépistage du cancer du sein comportant une mammographie et/ou une IRM chez les femmes présentant une densité mammaire extrêmement élevée (âge : 50 à 75 ans)
In this issue of the Journal, Geuzinge and colleagues demonstrate that in women with dense breasts, screening by magnetic resonance imaging (MRI) every 3 to 4 years is cost-effective compared with the current standard (ie, biannual mammographic screening) (1). The authors provide critical evidence for a simple fact: A more sensitive and more expensive diagnostic test is cost-effective, even if it is used for screening, compared with a less sensitive and less expensive test. Their publication thus provides long-awaited evidence on the economic practicability of the concept of risk-adjusted screening—and is therefore of pivotal importance.
Journal of the National Cancer Institute , commentaire en libre accès, 2020